"Algeria Pharmaceuticals & Healthcare Report Q1 2014" Now Available at Fast Market Research
Though we caution that operational risks in Algeria will remain elevated, the market is not only one of the largest in Africa, but also highly import-reliant, and thus of considerable interest of companies looking for new revenue sources. Government programmes for the modernisation of healthcare facilities will also support the development of per capita spending on pharmaceuticals going forward, although generic medicines will remain the largest beneficiaries of such trends, on account of public sector policies and low per capita...
View full press release